Vimarsana
Biggest News Aggregation in the World

Page 5 - Robert Barrow News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robert Barrow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robert Barrow Today - Breaking & Trending Today

Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 6.8% - Vimarsana News

Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 6.8%

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report)’s stock price rose 6.8% during mid-day trading on Tuesday . The company traded as high as $9.35 and last traded at $9.27. Approximately 577,000 shares traded hands during mid-day trading, a decline of 70% from the average daily volume of 1,919,400 shares. The stock had previously […]

Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 6.8% - Vimarsana News

Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 6.8%

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report)’s stock price rose 6.8% during mid-day trading on Tuesday . The company traded as high as $9.35 and last traded at $9.27. Approximately 577,000 shares traded hands during mid-day trading, a decline of 70% from the average daily volume of 1,919,400 shares. The stock had previously […]

Source: wkrb13.com
Jim Cramer Slams Political Blocking Of 'LSD-Derived Antidepressants,' Citing Strong Test Data 'Showing They Worked' - ATAI Life Sciences (NASDAQ:ATAI), Compass Pathways (NASDAQ:CMPS) - Vimarsana News

Jim Cramer Slams Political Blocking Of 'LSD-Derived Antidepressants,' Citing Strong Test Data 'Showing They Worked' - ATAI Life Sciences (NASDAQ:ATAI), Compass Pathways (NASDAQ:CMPS)

Jim Cramer Slams Political Blocking Of 'LSD-Derived Antidepressants,' Citing Strong Test Data 'Showing They Worked' - Vimarsana News

Jim Cramer Slams Political Blocking Of 'LSD-Derived Antidepressants,' Citing Strong Test Data 'Showing They Worked'

Jim Cramer recently hyped up one of his guests in advance of his CNBC show "Mad Money," posting on X that people "will be very interested in MindMed for certain ... LSD," and he made sure his interview did not disappoint. Mind Medicine Inc. (NASDAQ:MNMD) sees a massive market opportunity ahead, citing 21% of U.S. adults with an anxiety disorder, an estimated 4.4% of U.S. adults with attention-deficit/hyperactivity disorder (ADHD) and a $461 billion economic cost from autism spectrum disorder by

Source: yahoo.com
Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 7.3% - Vimarsana News

Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 7.3%

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report)’s share price traded up 7.3% during trading on Wednesday . The company traded as high as $10.93 and last traded at $10.78. 988,045 shares changed hands during trading, a decline of 50% from the average session volume of 1,992,814 shares. The stock had previously closed at […]